Regulation

Antitrust policy should adjust to the way innovation really happens, Martin Neil Baily and Matthew J. Slaughter write in a guest commentary.

Assumable loans allow a buyer to take on a seller’s mortgage. Portable loans allow sellers to keep their loan when they move. Each has pros and cons.

The membership clubs charge annual fees for access to doctors, extra testing, and perks like an Oura ring. Are they worth the cost?

The meat supplier faces falling beef and pork volumes, but chicken sales are bucking the trend.

Thousands of flights in the U.S. have been canceled or delayed Sunday, including hundreds of flights at Newark Liberty and Hartsfield-Jackson International Airport in Atlanta, according to FlightAware.com.

The American Association of Meat Processors didn’t immediately respond to a request for comment.

Though the immediate impact of Mamdani’s win is limited, the signal it sends is not. Americans are increasingly comfortable voting for heavy-handed government.

The project is an expansion of a natural-gas pipeline network that stretches from Texas to New York, carrying 15% of the nation’s natural gas.

“The builders have got to start building,” Federal Housing Finance Agency director Bill Pulte said at a Friday conference.

Most major airports across the country are affected.

The company is opening a massive plant in Michigan to make a critical component of solar panels. It’s going toe to toe with China.

The agreement, announced by the White House, potentially unlocks a major new market for the mega-blockbuster drugs.

Revenue for AppLovin’s mobile advertising business was up 68% on the year to $1.41 billion.

The top regulator is staying silent on key questions as sports events contracts displace online booksmakers.

When the shutdown ends, Chairman Paul Atkins says the Securities and Exchange Commission will look at expanding retirement plans’ access to alternatives and modifying the accredited investor rule.

From 2018 to 2024, First Trust wholesalers handed out lavish gifts as part of an aggressive sales strategy, brokerage-industry regulator Finra alleges.

Pfizer has now filed a suit in federal court, following its claim in state court on Friday. It is riding Trump-era political currents in its efforts to save the deal.

A New Jersey court recently stripped 1-800-Gambler of its national sponsor and millions in donations. Some advocates of problem gambling prevention are breathing a sigh of relief.

Seven lawmakers including Elizabeth Warren sign a letter expressing skepticism about how risky products can co-exist with retirement-plan advisors’ fiduciary duties.

Mutual fund share classes of ETFs could strongly benefit retirement savers, Anna Paglia writes in a guest commentary.

Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on clinical and regulatory milestones.

Alarm over increased lending is misplaced, Mike Kelly writes in a guest commentary.

Advisor exams and registrations are on pause as a bare-bones Securities and Exchange Commission focuses on market manipulation.

The restart of an abandoned South Carolina project would be the most dramatic example yet of a nuclear comeback in the U.S.

The FDA approved the treatment in 2020 but withdrew the go-ahead in 2022.